Stress Management Programs in Fire-fighters

May 12, 2014 updated by: Frédéric Dutheil, French Defence Health Service

Stress Management Programs in Fire-fighters of Paris: a Randomized Controlled Trial

Chronic stress at work is a public health problem increasing morbidity and mortality, especially in men. Among the men military populations, the firefighters of Paris (FFPs) are particularly exposed. To deal with this stress and to improve stress management is challenging. Psychological fitness is required to regulate emotions which improve effectiveness under stress and enhance recovery from stressful events. The heart coherence (HC) program uses feedback from a simple pulse sensor to reflect changes of the emotional/psychological state, and to learn how to reduce stress and stabilize emotions. Another kind of psychological fitness focuses on cognitive training to regulate emotions, with the use of techniques to optimize potential (TOP). The TOP consists of learning easy techniques in mental skills to improve cognitive-based problem-solving using respiration, relaxation, and visualization. Although never published in a peer-review journal, the procedure of TOP training is structured and standardized for individuals and groups, and is widely practiced in air traffic controllers, with apparently good effects.

Moreover, any event can be emotionally ambiguous, providing both negative and positive outcomes. The interpretation of such ambiguity is linked with an individual's emotional state, such as anxiety or mood. Individuals with a high level of trait anxiety are likely to interpret an event negatively.

However, no studies have compared the effect of HC or TOP in the perceived stress of FFPs. Nor have long-term effects of these stress management programs (SMP) been investigated. Furthermore, the influence of trait anxiety on stress levels in FFPs needs to be clarified. Finally, no trials have assessed levels of biomarkers stress following these SMP.

From these observations, we hypothesized that 1) young recruits aiming to become FFPs will be particularly exposed to stress, 2) SMP will be effective in reducing perceived stress, 3) SMP will mainly benefit FFPs who have high anxiety, and 4) the effects of SMP will lower levels of biomarkers of stress.

The aim of this randomized control trial is to evaluate the effectiveness of stress management programs on perceived stress (primary outcome variable), and on negative mood, mindfulness, and biomarkers of stress (secondary outcome variables) in FFPs. We also aim to investigate the influence of anxiety on the stress management programs effectiveness long-term.

Study Overview

Detailed Description

The army's FFPs unit recruits new FFPs each month who received a twelve-month contract comprising of a six-month induction program (1st month to 6th month) and a six-month active duty period (6th month to 12th month). Within our study, volunteers will be included at the 4th month (baseline measurements after the first four months of training), in order to avoid the high drop-out rate that occurs during the beginning of this period. Included participants will be randomly assigned (computer-generated randomization) to one of the three following groups: TOP, HC, or control, and the stress managements programs will occur during the last two months of induction program (4th month to 6th month). The two stress managements programs will be taught by an experimented psychologist, with daily requirements of short practice tasks. All three groups will receive a pharmaceutical placebo in order to control any placebo effect. The placebo will comprise of starch concealed in a capsule, and was required to be consumed between the 4th month and the 6th month.

The primary outcome will be perceived stress. Secondary outcomes will be changes in mood, mindfulness and biomarkers of stress.

All baseline assessments (4th month) will be repeated three times: at the end of the stress managements programs (6th month), at the end of the six-month active duty period (12th month) and at the 18th month.

Enrolment will set to end when 180 FFPs (60 per group) will be included. We estimated that with 55 participants in each group, the study would have more than 80% power to detect a clinically important difference among the groups in the change of perceived stress, at an alpha level of 5%.

Gaussian distribution of the data wil be tested by the Kolmogorov-Smirnov test. Data will be presented as mean ± standard deviation (SD). Comparisons between groups will be made with Wilcoxon matched-pairs test or ANOVA when appropriate. Relationships between data will be assessed by Pearson correlation, a Principal Components Analysis or a multivariable generalized estimating equations model when appropriate. Significance will be accepted at the p<0.05 level. Statistical procedures will be performed using SPSS Advanced Statistics software (SPSS Inc., Chicago, IL).

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75000
        • Paris Fire Brigade

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • male starting the formation to be a firefighter of Paris

Exclusion Criteria:

  • female
  • endocrine disease
  • recent extraprofessional life stress event (such as death of a near relative, divorce)
  • previous psychological training
  • current illness
  • medications used to modulate inflammatory diseases (corticosteroids, anti-inflammatory drugs, immunomodulatory drugs)
  • medications with a chronotropic effect taken over the previous six months (such as beta blockers, diltiazem, verapamil, anxiolytics or antidepressants)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: techniques to optimize potential (TOP)
The TOP consists of learning easy techniques in mental skills to improve cognitive-based problem-solving using respiration, relaxation, and visualization.
Active Comparator: heart coherence (HC)
The heart coherence (HC) is based on the fact that the heart rhythm becomes more erratic with negative emotions such as anger and anxiety, and more ordered/coherent with sustained positive emotions such as appreciation, love, or compassion, leading to optimal performance and well-being. The HC program uses feedback from a simple pulse sensor to reflect changes of the emotional/psychological state, and to learn how to reduce stress and stabilize emotions.
Placebo Comparator: controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Perceived stress at the end of the stress managements programs
Time Frame: All baseline assessments (4th month) will be repeated three times: at the end of the stress managements programs (6th month), at the end of the six-month active duty period (12th month) and at 18th month.
Perceived stress scale (PSS)
All baseline assessments (4th month) will be repeated three times: at the end of the stress managements programs (6th month), at the end of the six-month active duty period (12th month) and at 18th month.

Secondary Outcome Measures

Outcome Measure
Time Frame
the profile of mood states (POMS)
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
the Freiburg Mindfulness Inventory-14
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
the Spielberger State-Trait-Anxiety Inventory (S-STAI)
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
heart rate variability
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
salivary cortisol
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
salivary immunoglobulin A
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month
urinary catecholamines
Time Frame: 4th month (baseline), 6th month, 12th month, and 18th month
4th month (baseline), 6th month, 12th month, and 18th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

May 2, 2014

First Submitted That Met QC Criteria

May 12, 2014

First Posted (Estimate)

May 14, 2014

Study Record Updates

Last Update Posted (Estimate)

May 14, 2014

Last Update Submitted That Met QC Criteria

May 12, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • n° EudraCT 2010-A00212-37

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on techniques to optimize potential (TOP)

3
Subscribe